New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
10:00 EDTRCL, TEVA, MDLZ, VOLC, SF, NVS, ZIOP, STX, NOV, BXP, XEL, PTEN, IEXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: IDEX Corp. (IEX) downgraded to Hold from Buy at Brean Capital... National Oilwell (NOV) downgraded to Outperform from Buy at CLSA... Novartis (NVS) downgraded to Hold from Buy at Deutsche Bank... Patterson-UTI Energy (PTEN) downgraded to Outperform from Buy at CLSA... Seagate (STX) downgraded to Underweight from Neutral at JPMorgan... Stifel Financial (SF) downgraded to Underperform from Market Perform at Wells Fargo... Xcel Energy (XEL) downgraded to Neutral from Outperform at Macquarie... Ziopharm (ZIOP) downgraded to Hold from Buy at Jefferies... Boston Properties (BXP) downgraded to Hold from Buy at Stifel Nicolaus... Volcano (VOLC) downgraded to Neutral from Outperform at Credit Suisse... Teva (TEVA) downgraded to Market Perform from Outperform at Leerink... Royal Caribbean (RCL) downgraded to Neutral from Buy at Longbow... Mondelez (MDLZ) downgraded to Hold from Buy at Argus.
News For IEX;NOV;NVS;PTEN;STX;SF;XEL;ZIOP;VOLC;BXP;TEVA;RCL;MDLZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 9, 2015
06:15 EDTTEVACiti does not see much strategic sense in Mylan, Perrigo deal
Subscribe for More Information
05:49 EDTTEVAStocks with implied volatility movement; MYL TEVA
Subscribe for More Information
April 8, 2015
16:34 EDTIEXIDEX Corp. raises quarterly dividend by 14% to 32c per share
Subscribe for More Information
16:22 EDTNVS, TEVAOn The Fly: Closing Wrap
Subscribe for More Information
14:23 EDTNVS, TEVAAdditional bidders for Perrigo could emerge after Mylan offer, says Stifel
Subscribe for More Information
13:07 EDTTEVAMylan bid for Perrigo makes strategic sense, says JPMorgan
Subscribe for More Information
12:37 EDTTEVATeva downgraded to Hold from Buy at Standpoint Research
Subscribe for More Information
08:06 EDTSFNASDAQ, KBW announce strategic partnership
Subscribe for More Information
07:22 EDTBXPEvercore ISI to hold a conference
Subscribe for More Information
07:16 EDTTEVAMylan one of the cheapest names in Specialty Pharma, says JPMorgan
Subscribe for More Information
April 7, 2015
15:24 EDTTEVATeva price target raised to $75 from $64 at BMO Capital
BMO Capital raised its EPS estimates for Teva (TEVA) and increased its price target on the stock to $75 from $64 on account of the expected launch of a treatment for chorea associated with Huntington’s disease in 3Q16 and a launch of a tardive dyskinesia drug in 3Q17 following the company's deal to buy Auspex (ASPX). The firm maintains its Outperform rating on Teva shares.
15:03 EDTSTXSeagate April volatility elevated
Subscribe for More Information
09:35 EDTSTXActive equity options trading on open
Subscribe for More Information
08:06 EDTSTXSeagate says LaCie doubles capacity of Rugged Thunderbolt SSD
LaCie, the premium brand from Seagate Technology, announced that its Rugged Thunderbolt storage solution will be available in a 1 TB SSD capacity. With double the storage, the new LaCie Rugged is just as portable with no size or weight increase compared to the 500 GB offering.
07:14 EDTNVSEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
April 6, 2015
13:52 EDTMDLZIndia imposes $88M tax fine on Cadbury, Reuters says
Indian tax authorities have imposed an $88M fine on Mondelez' Cadbury unit, reports Reuters, citing government officials. The government claims Cadbury misused a "tax holiday" strategy for a factory in Himachal Pradesh. Mondelez India said its tax exemptions for the period are legal, noting that "the issue is one of interpretation." Reference Link
13:35 EDTSTXSanDisk climbs after being identified as 'excellent' takeover target
Subscribe for More Information
08:13 EDTNVSJuno Therapeutics announces patent litigation settlement
Subscribe for More Information
05:56 EDTTEVATeva battles possible generic Copaxone competitors, Globes reports
A citizen's petition has been filed by Teva with the FDA against possible generic competition to its MS treatment Copaxone beginning in September, Globes reports. The FDA has previously ruled that it was "too early" to discuss the matter. Reference Link
April 5, 2015
08:43 EDTSTXAT&T, Philip Morris, eight others have reliable yields up to 5.7%, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use